Is there an optimal hemoglobin value in the cardiac intensive care unit?
Anemia is common in patients admitted to the cardiac intensive care unit. Many unique issues must be considered in the treatment of the anemic cardiac patient. Coronary artery disease and left ventricular dysfunction may significantly increase the risk of anemia. These patients have limited reserve because of a high extraction ratio of oxygen in the cardiac circulation. Left ventricular dysfunction increases the risk of complications from transfusion. Recent observational studies suggest that cardiac patients may benefit from a higher transfusion threshold. However, very few patients with cardiovascular disease have been included in clinical trials comparing high and low transfusion triggers. Experimental data and recent studies in humans suggest that cardiac patients may be intolerant of anemia. Pending definitive clinical trials in cardiac patients, we suggest a more aggressive transfusion trigger (9-10 g/dL) in patients with active cardiac disease. Pulmonary edema may be precipitated by transfusion in patients with left ventricular dysfunction. Large clinical trials are urgently needed to determine optimal transfusion thresholds in patients with cardiovascular disease.
D000740:Anemia / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D001803:Blood Transfusion; D001810:Blood Volume; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000503:physiopathology; D006331:Heart Diseases / Q000097:blood / Q000150:complications / Q000628:therapy*; D006333:Heart Failure / Q000097:blood / Q000503:physiopathology; D006454:Hemoglobins / Q000032:analysis* / Q000592:standards; D006801:Humans; D007362:Intensive Care Units; D016019:Survival Analysis
D006454:Hemoglobins